V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011691 | 240007903 | 1.53 | null | Disease modification (D) | 2017-02-16 | 2017-02-18 | Azacitidine | N | N | 240031753 | AZACITIDINE |
| 240011692 | 240007903 | 1.73 | 92.5 | Palliative (P) | 2014-01-08 | 2014-01-08 | Bevacizumab+Carbo+Pacliaxel | N | null | 240031753 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011693 | 240007905 | 1.73 | 72 | Palliative (P) | 2013-04-05 | 2013-04-09 | Carboplatin AUC 2 - 5 | N | N | 240031787 | CARBOPLATIN |
| 240011694 | 240012233 | 1.77 | 0 | Palliative (P) | 2015-01-07 | 2015-01-07 | Trial Unspecified | 02 | N | 240031788 | TRIAL |
| 240011695 | 240007906 | 1.81 | 61.6 | Palliative (P) | 2013-11-04 | 2013-11-09 | PACLITAXEL | N | null | 240031790 | PACLITAXEL |
| 240011696 | 240007907 | 0 | 53 | Palliative (P) | 2016-06-09 | 2016-06-09 | Bevacizumab 15mg/kg | N | null | 240031791 | BEVACIZUMAB |
| 240011697 | 240007909 | null | 62 | Curative (C) | 2017-10-20 | 2017-10-28 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 240031805 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011698 | 240007910 | 1.63 | 84.1 | Palliative (P) | 2015-04-24 | 2015-06-25 | Azacitidine | 2 | N | 240031811 | AZACITIDINE |
| 240011699 | 240012234 | 0.6 | null | Palliative (P) | 2017-08-05 | 2017-11-29 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240031820 | NOT MATCHED |
| 240011700 | 240007911 | 1.69 | null | Disease modification (D) | 2015-02-05 | 2015-02-09 | INTERLACE TRIAL | N | null | 240031827 | INTERLACE TRIAL |
| 240011701 | 240007912 | 1.6 | 45.8 | Palliative (P) | 2014-10-03 | 2014-10-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240031829 | PACLITAXEL |
| 240011702 | 240007913 | 1.74 | null | Palliative (P) | null | 2017-04-22 | Azacitidine | Y | N | 240031840 | AZACITIDINE |
| 240011703 | 240007913 | null | 47.9 | null | 2017-05-27 | 2017-06-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240031840 | PACLITAXEL |
| 240011704 | 240007914 | 1.62 | 62.4 | null | 2014-12-07 | 2014-12-07 | Azacitidine | 02 | N | 240031861 | AZACITIDINE |
| 240011705 | 240007916 | 1.69 | 86 | Curative (C) | 2017-06-28 | 2017-07-04 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240031863 | NOT MATCHED |
| 240011706 | 240012238 | 1.66 | 45.8 | Palliative (P) | 2014-01-20 | 2014-01-20 | Azacitidine | N | N | 240031870 | AZACITIDINE |
| 240011707 | 240012238 | null | 64 | Disease modification (D) | null | 2018-08-04 | Azacitidine | N | N | 240031870 | AZACITIDINE |
| 240011708 | 240007917 | 1.68 | 43 | Disease modification (D) | 2017-06-22 | 2017-06-22 | Methotrexate intrathecal | Y | N | 240031883 | METHOTREXATE INTRATHECAL |
| 240011709 | 240007917 | 1.76 | 63 | null | 2015-12-10 | 2015-12-13 | Bevacizumab | 2 | N | 240031883 | BEVACIZUMAB |
| 240011710 | 240007918 | null | 62.5 | Palliative (P) | 2015-02-03 | 2015-02-12 | INTERLACE TRIAL | N | N | 240031911 | INTERLACE TRIAL |
| 240011711 | 240007919 | null | 102.6 | Palliative (P) | 2016-09-15 | 2016-09-22 | Trial Unspecified | null | N | 240031913 | TRIAL |
| 240011712 | 240007920 | null | 87.2 | Palliative (P) | 2017-09-27 | 2017-09-27 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240031916 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011713 | 240007921 | 1.81 | 86.8 | Palliative (P) | 2017-02-19 | 2017-03-31 | Bevacizumab+Carbo+Pacliaxel | 2 | N | 240031919 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011714 | 240007925 | 1.61 | 72.2 | Curative (C) | null | 2014-03-20 | Bevacizumab | 2 | N | 240031919 | BEVACIZUMAB |
| 240011715 | 240007925 | 1.53 | 44.7 | Neo-adjuvant (N) | 2015-11-18 | 2015-11-25 | ALCL ALCL 99 Closed Pre Phase | N | N | 240031919 | NOT MATCHED |
| 240011716 | 240007926 | 1.66 | 142.7 | Disease modification (D) | 2015-05-07 | 2015-05-28 | CHOP-R + CYTARABINE | 2 | N | 240031937 | NOT MATCHED |
| 240011717 | 240007927 | null | 86.9 | Curative (C) | 2015-11-01 | 2015-11-30 | INTERLACE TRIAL | N | null | 240031937 | INTERLACE TRIAL |
| 240011718 | 240007927 | 2 | 44.8 | Adjuvant (A) | 2017-04-29 | 2017-04-29 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240031937 | NOT MATCHED |
| 240011719 | 240007927 | 1.62 | 114.5 | null | 2014-10-19 | 2014-10-24 | INTERLACE TRIAL | 2 | N | 240031937 | INTERLACE TRIAL |
| 240011720 | 240007929 | 1.67 | 89 | Curative (C) | null | 2016-01-04 | ALEMTUZUMAB + ETOPOSIDE + THIOTEPA | 02 | N | 240031944 | NOT MATCHED |
| 240011721 | 240007931 | 0 | null | null | 2014-02-07 | 2014-02-24 | CHOP - 21 days | 02 | null | 240031950 | CHOP |
| 240011722 | 240007931 | null | 17.85 | Palliative (P) | 2013-12-14 | 2013-12-27 | Bevacizumab+Carbo+Pacliaxel | null | null | 240031950 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011723 | 240007934 | 1.69 | 111.3 | Palliative (P) | 2014-12-05 | 2015-03-08 | PACLITAXEL | N | N | 240031958 | PACLITAXEL |
| 240011724 | 240007935 | 1.64 | 11.1 | Disease modification (D) | 2016-01-15 | 2016-01-15 | Azacitidine | 2 | N | 240031959 | AZACITIDINE |
| 240011725 | 240007936 | 0 | 63.6 | Palliative (P) | null | 2016-12-16 | Trial Unspecified | N | N | 240031961 | TRIAL |
| 240011726 | 240015313 | null | 103 | Neo-adjuvant (N) | null | 2016-11-13 | Methotrexate intrathecal | 02 | N | 240031965 | METHOTREXATE INTRATHECAL |
| 240011727 | 240015313 | 1.63 | 61.3 | null | 2015-02-02 | 2015-02-09 | CHOP - 21 days | N | N | 240031965 | CHOP |
| 240011728 | 240016110 | 0 | null | Disease modification (D) | 2013-06-30 | 2013-10-27 | Azacitidine | N | N | 240031969 | AZACITIDINE |
| 240011729 | 240007937 | 0 | 74.7 | Palliative (P) | 2014-05-26 | 2014-05-26 | Carboplatin AUC 2 - 5 | N | N | 240031970 | CARBOPLATIN |
| 240011730 | 240007938 | 1.65 | 73.3 | Palliative (P) | 2016-07-12 | 2016-07-28 | Trial Unspecified | N | N | 240031971 | TRIAL |
| 240011731 | 240007939 | 1.57 | 92 | Palliative (P) | 2018-02-01 | 2018-02-04 | Azacitidine | 02 | N | 240031977 | AZACITIDINE |
| 240011732 | 240007941 | 1.74 | 80 | Curative (C) | 2016-01-11 | 2016-01-13 | Carboplatin AUC 2 - 5 | 2 | N | 240031977 | CARBOPLATIN |
| 240011733 | 240007941 | 1.49 | 87 | Palliative (P) | 2016-10-18 | 2016-10-23 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 240031977 | NOT MATCHED |
| 240011734 | 240016111 | 1.69 | 72.2 | Disease modification (D) | 2013-05-22 | 2013-06-03 | INTERLACE TRIAL | N | N | 240031988 | INTERLACE TRIAL |
| 240011735 | 240012251 | null | 52.6 | Palliative (P) | 2014-07-19 | 2014-08-17 | PACLITAXEL | 99 | N | 240031993 | PACLITAXEL |
| 240011736 | 240012253 | 0 | 31 | Adjuvant (A) | 2015-07-20 | 2015-07-27 | INTERLACE TRIAL | N | N | 240031996 | INTERLACE TRIAL |
| 240011737 | 240012254 | null | null | Palliative (P) | 2016-06-05 | 2016-07-05 | Trial Unspecified | 2 | N | 240032002 | TRIAL |
| 240011738 | 240007947 | 1.7 | 62.8 | Neo-adjuvant (N) | 2014-06-06 | 2014-06-24 | Bevacizumab 15mg/kg | N | N | 240032005 | BEVACIZUMAB |
| 240011739 | 240007949 | null | 107.6 | Palliative (P) | 2018-07-18 | 2018-07-18 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032012 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011740 | 240007950 | null | null | Palliative (P) | 2016-06-21 | 2016-10-17 | Bevacizumab 15mg/kg | null | null | 240032030 | BEVACIZUMAB |